Enzyme stabilization in nanostructured materials, for use in organophosphorus nerve agent detoxification and prophylaxis

NATO Science for Peace and Security Series A: Chemistry and Biology

Volumn , Issue , 2011, Pages 135-145

  Kernchen, R J ^a  

^a FRAUNHOFER INT   (Germany)

Author keywords

Detoxification; Enzymes; Nanostructured materials; Organophosphorus

Indexed keywords

BACTERIA (MICROORGANISMS);

EID: 78751668008     PISSN: 18746489     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-94-007-0217-2_14     Document Type: Article

References (38)

1. Munro NB, Ambrose KR et al (1994) Toxicity of the organophosphate chemical warfare agents GA, GB, and VX: implications for public protection. Environ Health Perspect 102(1):18-38
2. Karpouzas DG, Sing BK (2006) Microbial degradation of organophosphorus xenobiotics: Metabolic pathways and molecular basis. Adv Microb Physiol 51:119-185
3. Gordon RK, Clarkson ED et al (2009) Rapid decontamination of chemical warfare agents. In: Handbook of toxicology of chemical warfare agents. Academic Press, San Diego, pp 1069-1081
4. Yair S, Ofer B et al (2008) Organophosphate degrading microorganisms and enzymes as biocatalysts in environmental and personal decontamination applications. Crit Rev Biotechnol 28(4):265-275
5. Richardt A, Blum MM (eds) (2008) Decontamination of warfare agents. Enzymatic methods for the removal of B/C weapons. Wiley-VCH Verlag GmbH& Co. KgaA, Weinheim
6. Rochu D, Chabriere E et al (2007) Human paraoxonase: A promising approach for pretreatment and therapy of organophosphorus poisoning. Toxicology 233(1-3):47-59
7. Doctor BP, Saxena A (2005) Bioscavengers for the protection of humans against organophosphate toxicity. Chem-Biol Interact 157-158; 167-171
8. Ó'Fágáin C (2003) Enzyme stabilization - recent experimental progress. Enzyme Microb Technol 33(2-3):137-149
9. Polizzi KM, Bommarius AS et al (2007) Stability of biocatalysts. Curr Opin Chem Biol 11(2):220-225
10. Betancor L, Luckarift HR (2008) Bioinspired enzyme encapsulation for biocatalysis. Trends Biotechnol 26(10):566-572
11. Cao L (2005) Immobilised enzymes: Science or art? Curr Opin Chem Biol 9(2):217-226
12. Zhao XS, Bao XY et al (2006) Immobilizing catalysts on porous materials. Mater Today 9(3):32-39
13. Wang P (2009) Multi-scale features in recent development of enzymatic biocatalyst systems. Appl Biochem Biotechnol 152(2):343-352
14. Sahoo SK, Parveen S et al (2007) The present and future of nanotechnology in human health care. Nanomed Nanotechnol Biol Med 3(1):20-31
15. Wang P (2006) Nanoscale biocatalyst systems. Curr Opin Biotechnol 17(6):574-579
16. Wang Z-G, Wan L-S et al (2009) Enzyme immobilization on electrospun polymer nanofibers: An overview. J Mol Catal B Enzym 56(4):189-195
17. Ge J, Lu D et al (2009) Recent advances in nanostructured biocatalysts. Biochem Eng J 44(1):53-59
18. Kim J, Grate JW et al (2008) Nanobiocatalysis and its potential applications. Trends Biotechnol 26(11):639-646
19. Kernchen RJ, Jovanovic M (2009). Nanobiokatalyse. Bibliometrische Analyse des F&E-Gebietes, Arbeitsbericht 27-09. Euskirchen, Fraunhofer Institute for Technological Trend Analysis (INT): 1-9
20. Ghanem E, Raushel FM (2005) Detoxification of organophosphate nerve agents by bacterial phosphotriesterase. Toxicol Appl Pharmacol 207(2, Supplement 1):459-47
21. Russell AJ, Berberich JA et al (2003) Biomaterials for mediation of chemical and biological warfare agents. Annu Rev Biomed Eng 5(1):1-27
22. Drevon GF, Russell AJ (2000) Irreversible immobilization of diisopropylfluorophosphatase in polyurethane polymers. Biomacromolecules 1(4):571-576
23. LeJeune KE, Swers JS et al (1999) Increasing the tolerance of organophosphorus hydrolase to bleach. Biotechnol Bioeng 64(2):250-254
24. Taguchi A, Schüth F (2005) Ordered mesoporous materials in catalysis. Microporous Mesoporous Mater 77(1):1-45
25. Lei CH, Soares TA et al. (2008) Enzyme specific activity in functionalized nanoporous supports. Nanotechnology 19(12)
26. Lee C-H, Lin T-S et al (2009) Mesoporous materials for encapsulating enzymes. Nano Today 4(2):165-179
27. Lei CH, Shin YS et al (2002) Entrapping enzyme in a functionalized nanoporous support. J Am Chem Soc 124(38):11242-11243
28. Ong KK, Dong H et al. (2003) Nanoencapsulation of OPAA with mesoporous materials for chemical agent decontamination in organic solvents. DoD Joint service scientific conference on chem& bio defense research, Hunt Valley (MD)
29. Cheng TC, Rastogi VK et al. (2003). Compatibility of CW agent degrading enzymes with disinfectants and foams. Proceedings of the joint service sientific conference on chemical& biological defense research, Hunt Valley, USA
30. Petrikovics I, Papahadjopoulos D et al (2004) Comparing therapeutic and prophylactic protection against the lethal effect of paraoxon. Toxicol Sci 77(2):258-262
31. Petrikovics I, Hong K et al (1999) Antagonism of paraoxon intoxication by recombinant phosphotriesterase encapsulated within sterically stabilized liposomes. Toxicol Appl Pharmacol 156(1):56-63
32. Leroux J-C (2007) Injectable nanocarriers for biodetoxification. Nat Nano 2(11):679-684
33. Petrikovics I, McGuinn WD et al (2000) In vitro studies on sterically stabilized liposomes (SL) as enzyme carriers in organophosphorus (OP) antagonism. Drug Deliv 7(2):83-89
34. Petrikovics I, Wales ME et al (2007) Enzyme-based intravascular defense against organophosphorus neurotoxins: Synergism of dendritic-enzyme complexes with 2-PAM and atropine. Nanotoxicology 1(2):85-92
35. Immordino ML, Dosio F et al (2006) Stealth liposomes: Review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomedicine 1(3):297-315
36. Budai M, Chapela P et al (2009) Physicochemical characterization of stealth liposomes encapsulating an organophosphate hydrolyzing enzyme. J of Liposome Research 19(2):163-168
37. Petrikovics I, Cheng TC et al (2000) Long circulating liposomes encapsulating organophosphorus acid anhydrolase in diisopropylfluorophosphate antagonism. Toxicol Sci 57(1):16-21
38. Svenson S, Tomalia DA (2005) Commentary - Dendrimers in biomedical applications - reflections on the field. Adv Drug Deliv Rev 57(15):2106-2129